PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide
Maximal PSA response, PSA nadir, and time to PSA nadir correlated with survival in patients with castration-resistant prostate cancer receiving enzalutamide as a first-line therapy.
Authors
- Masaru Tani (ORCID: https://orcid.org/0009-0001-3079-0520)
- Akinaru Yamamoto
- Toshihiro Uemura
- Gaku Yamamichi
- Koji Hatano (ORCID: https://orcid.org/0000-0002-8409-5152)
- Atsunari Kawashima (ORCID: https://orcid.org/0000-0001-9369-4264)
- Toshitaka Oka (ORCID: https://orcid.org/0000-0003-0871-2793)
- Yu Ishizuya (ORCID: https://orcid.org/0000-0003-0778-1308)
- Yoshiyuki Yamamoto (ORCID: https://orcid.org/0000-0002-2932-5904)
- Kazutoshi Fujita (ORCID: https://orcid.org/0000-0002-6774-7497)
- Taigo Kato (ORCID: https://orcid.org/0000-0002-8681-1407)
- Yuki Horibe (ORCID: https://orcid.org/0000-0002-4809-9498)
- Norio Nonomura (ORCID: https://orcid.org/0000-0002-6522-6233)
- Yutong Liu (ORCID: https://orcid.org/0009-0009-3844-9456)
- Nesrine Sassi
- Akihiro Yoshimura
- Yohei Okuda (ORCID: https://orcid.org/0000-0001-9909-4200)
Institutions
- Kindai University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Cancer Diagnosis & Prognosis
- Published
- 2024-11-02
- DOI
- https://doi.org/10.21873/cdp.10385
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.84